or Try an Advanced Search...

    Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    XOMA A XOMA Corporation 1.40
    HCM A Hutchison China MediTech Limited -0.55
    CRIS A Curis, Inc. -4.58
    LYEL B Lyell Immunopharma, Inc. -2.10
    CGEM B Cullinan Management, Inc. 1.01
    CNTA B Centessa Pharmaceuticals plc -2.32
    ACHV B Achieve Life Sciences, Inc. 0.00
    NXTC B NextCure, Inc. 3.97
    BCAB C BioAtla, Inc. -3.95
    EVAX C Evaxion Biotech A/S 2.68
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Cancer Small Cell Lung Cancer Solid Tumors Biopharmaceutical Clinical Medicine Medicine Cancer Immunotherapy Drugs Immunotherapy Tumor Antibodies Biotechnology Bladder Cancer Breast Cancer Drug Discovery Gastric Cancer Hematological Cancers Immune System Immunology Lung Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 3.86
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.75
    FORH A Formidable ETF 1.83
    FDM C First Trust DJ Select MicroCap ETF 0.97
    GNOM D Global X Genomics & Biotechnology ETF 0.55
    View all Non Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare BBC to GNOM Compare CNCR to FORH Compare FDM to GNOM

        Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        Apr 17 EVAX Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01
        Apr 16 LYEL Lyell Immunopharma: Testing The T-Cell Thesis With 2 Upcoming Data Catalysts
        Apr 16 CGEM Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity
        Apr 16 CGEM UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
        Apr 16 CGEM Cullinan Therapeutics expands into autoimmune diseases
        Apr 16 CGEM Cullinan Therapeutics gets $280M via oversubscribed private placement
        Apr 16 CGEM Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
        Apr 16 CGEM Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
        Apr 16 CGEM Cullinan changes name, pivots to autoimmune disease
        Apr 12 CRIS Top 3 Health Care Stocks That May Collapse In Q2
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Cancer Small Cell Lung Cancer Solid Tumors Biopharmaceutical Clinical Medicine Medicine Cancer Immunotherapy Drugs Immunotherapy Tumor Antibodies Biotechnology Bladder Cancer Breast Cancer Drug Discovery Gastric Cancer Hematological Cancers Immune System Immunology Lung Cancer
        Non Small Cell Lung Cancer

        Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. It is a type of cancer that begins in the cells that line the airways of the lungs. NSCLC is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Symptoms of NSCLC include a persistent cough, chest pain, shortness of breath, and coughing up blood. Treatment options for NSCLC include surgery, chemotherapy, radiation therapy, and targeted therapy.

        Browse All Tags